Neuropsychopharmacology
- In Memoriam: Larry J. Young, PhD2 years ago
- Extinction training suppresses activity of fear memory ensembles across the hippocampus and alters transcriptomes of fear-encoding cells2 years ago
- Genome-wide association studies of coffee intake in UK/US participants of European ancestry uncover cohort-specific genetic associations2 years ago
- Cracking the chicken and egg problem of schizophrenia and substance use: Genetic interplay between schizophrenia, cannabis use disorder, and tobacco smoking2 years ago
- Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci2 years ago
- Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam2 years ago
- Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks2 years ago
Journal of Psychopharmacology
- The cortical silent period in schizophrenia: A systematic review and meta-analysis focusing on disease stage and antipsychotic medication4 years ago
- Catechol-O-methyltransferase activity does not influence emotional processing in men4 years ago
- To BDZ or not to BDZ? That is the question! Is there reliable scientific evidence for or against using benzodiazepines in the aftermath of potentially traumatic events for the prevention of PTSD? A systematic review and meta-analysis4 years ago
- Do antipsychotic drugs shrink the brain? Probably not4 years ago
- The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms4 years ago
- Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms4 years ago
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension4 years ago
European Neuropsychopharmacology
- Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders4 years ago
- Polygenic risk scores for antisocial behavior in relation to amygdala morphology across an attention deficit hyperactivity disorder case-control sample with and without disruptive behavior4 years ago
- Letter to the editor about the article “Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders” (Schulze TG et al., 2022)4 years ago
- Early intervention and staging bipolar disorder: Conceptual and clinical dilemmas4 years ago
- Non-prescribed use of gabapentinoids: Mechanisms, predisposing factors, associated hazards and clinical management4 years ago
- Erratum to “Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100–116]”4 years ago
- Comment to “Requiem or resurrection: Classic monoamine oxidase inhibitors revisited”4 years ago